e-learning
resources
Barcelona 2013
Saturday, 07.09.2013
PG9 How to optimise antibiotic use in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Antibiotic use in special populations: renal failure and the obese patient
F. Scaglione (Milan, Italy)
Source:
Annual Congress 2013 –PG9 How to optimise antibiotic use in respiratory infections
Session:
PG9 How to optimise antibiotic use in respiratory infections
Session type:
Postgraduate Course
Number:
25
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Scaglione (Milan, Italy). Antibiotic use in special populations: renal failure and the obese patient. Annual Congress 2013 –PG9 How to optimise antibiotic use in respiratory infections
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Hosny Raef Emam - 27.09.2013 00:36
I can't open the file on iPad.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Antibiotic therapy of the CAP at young patients from different social groups
Source: Eur Respir J 2003; 22: Suppl. 45, 451s
Year: 2003
Microbiological impact of regular colistin use in a population of lung transplant recipients
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012
Antibiotic use in children: another increased risk of asthma?
Source: Breathe 2009; 6: 64-65
Year: 2009
Pulmonary dysfunctions in end stage chronic renal failure (ESCRF) children on regular hemodialysis: possible risk factors
Source: Annual Congress 2007 - Paediatric respiratory physiology in health and disease
Year: 2007
CAP in special populations: the patient with HIV and the patient with COPD
Source: Annual Congress 2007 - An international perspective of the management of hospitalised patients with community-acquired pneumonia
Year: 2007
Prevalence and outcomes of diabetes in lung transplant recipients: the portuguese experience
Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Year: 2020
Antibiotic usage analysis of the community-acquired pneumonia at young patients from different social groups
Source: Eur Respir J 2003; 22: Suppl. 45, 149s
Year: 2003
Survival benefit of lung transplantation compared with medical management and pulmonary rehabilitation for patients with end-stage COPD
Source: ERJ Open Res, 6 (2) 00177-2019; 10.1183/23120541.00177-2019
Year: 2020
Side-effects of antituberculosis drug treatment in patients with chronic renal failure
Source: Eur Respir J 2002; 20: 440-443
Year: 2002
Changes in empirical initial antibiotic therapy in community-acquired pneumonia: assessment of clinical failure versus discordant therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 736s
Year: 2006
Management of chronic respiratory failure in obese patients
Source: Annual Congress 2004 - Noninvasive ventilation for respiratory failure in obese patients
Year: 2004
Antibiotic resistance in ambulatory patients with chronic obstructive pulmonary disease–clinical signs
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Pleuro-pulmonary changes in patients suffering from end-stage renal disease receiving regular hemodialysis
Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases
Year: 2011
Antibiotic resistance and clinical outcomes: the CAPNETZ experience
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006
Diagnosis of osteoporosis in adult CF patients: the need for careful evaluation
Source: Eur Respir J 2001; 18: Suppl. 33, 539s
Year: 2001
Cardiopulmonary exercise testing and critical care use after high risk elective surgery for patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Clinical exercise physiology
Year: 2013
Is preoperative pulmonary evaluation necessary in renal transplant patients?
Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings
Year: 2018
Characteristics of pneumonia course at the patients with renal insufficiency receiving hemodialysis
Source: Annual Congress 2010 - Unusual pathogens in respiratory infections
Year: 2010
Impact of the duration of renal replacement therapy on the respiratory complications in patients with end-stage renal disease
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Effects of physiotherapy intervention in chronic renal failure patients during hemodialysis
Source: Annual Congress 2010 - Exercise training: new groups, new methods and outcomes
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept